Journal of Cancer Prevention

eISSN 2288-3657
pISSN 2288-3649

Clinicopathological and treatment related characteristics of colorectal cancer patients in TASH Oncology Department, Addis Ababa, Ethiopia

Variable Category Status at last contact Total

Death Censored
Primary site of tumor Colon 122 (34.9) 228 (65.1) 350 (56.4)
Rectum 80 (29.5) 191 (70.5) 271 (43.6)
Stage of the diseasesa Stage I 4 (8.0) 46 (92.0) 50 (8.1)
Stage II 33 (20.2) 130 (79.8) 163 (26.2)
Stage III 66 (27.1) 178 (72.9) 244 (39.3)
Stage IV 99 (60.4) 65 (39.6) 164 (26.4)
Grade Differentiated 70 (23.6) 226 (76.4) 296 (47.7)
Moderately differentiated 51 (29.7) 121 (70.3) 172 (27.7)
Undifferentiated 81 (52.9) 72 (47.1) 153 (24.6)
Histology type Adenocarcinoma 148 (30.3) 340 (69.7) 488 (78.6)
mucinous carcinoma 36 (38.7) 57 (61.3) 93 (15.0)
Signet ring-cell carcinoma 18 (45.0) 22 (55.0) 40 (6.4)
Treatment modality Radiotherapy alone 11 (31.4) 24 (68.6) 35 (5.6)
Surgical treatment alone 10 (24.4) 31 (75.6) 41 (6.6)
Chemotherapy alone 41 (34.2) 79 (65.8) 120 (19.3)
Surgery plus chemotherapy 53 (28.5) 133 (71.5) 186 (30.0)
Radiation as neo-adjuvant to surgery 19 (31.1) 42 (68.9) 61 (9.8)
Radiation + surgery chemotherapy 67 (38.3) 108 (61.7) 175 (28.2)
Didn’t receive treatment 1 (33.3) 2 (66.7) 3 (0.5)

The total number of 621 subjects were selected from patients registered between January 1, 2013 and December 30, 2017 with follow-up until December 30, 2018. Values are presented as number (%). TASH, Tikur Anbessa Specialized Hospital. aAccording to American Joint Committee of Cancer.

Journal of Cancer Prevention 2020;25:38~47 https://doi.org/10.15430/JCP.2020.25.1.38
© J Cancer Prev
Copyright © Korean Society of Cancer Prevention. / Powered by INFOrang Co., Ltd